The classical problem of identifying the optimal risk transfer from one insurance company to multiple reinsurance companies is examined under some quantilebased risk measure criteria. We develop a new methodology via a two-stage optimisation procedure which allows us to not only recover some existing results in the literature, but also makes possible the analysis of high dimensional problems in which the insurance company diversifies its risk with multiple reinsurance counter-parties, where the insurer risk position and the premium charged by the reinsurers are functions of the underlying risk quantile. Closed form solutions are elaborated for some particular settings, although numerical methods for the second part of our procedure represent viable alternatives for the ease of implementing it in more complex scenarios. Furthermore, we discuss some approaches to obtain more robust results.
This is the accepted version of the paper.This version of the publication may differ from the final published version.
Permanent repository link
AbstractWe develop portfolio optimization problems for a non-life insurance company seeking to find the minimum capital required, which simultaneously satisfies solvency and portfolio performance constraints. Motivated by standard insurance regulations, we consider solvency capital requirements based on three criteria: Ruin Probability, Conditional Value-at-Risk and Expected Policyholder Deficit ratio. We propose a novel semiparametric formulation for each problem and explore the advantages of implementing this methodology over other potential approaches. When liabilities follow a Lognormal distribution, we provide sufficient conditions for convexity for each problem. Using different expected Return on Capital target levels, we construct efficient frontiers when portfolio assets are modelled with a special class of multivariate GARCH models. We found that the correlation between asset returns plays an important role in the behaviour of the optimal capital required and the portfolio structure. The stability and out-of-sample performance of our optimal solutions are empirically tested with respect to both the solvency requirement and portfolio performance, through a double rolling window estimation exercise.
In this paper we propose semiclosed‐form solutions, subject to an inversion of the Fourier transform, for the price of VIX options and target volatility options under affine GARCH models based on Gaussian and Inverse Gaussian distributions. We illustrate the advantage of the proposed analytic expressions by comparing them with those obtained from benchmark Monte–Carlo simulations. The empirical performance of the two affine GARCH models is tested using different calibration exercises based on historical returns and market quotes on VIX and SPX options.
Under discrete-time GARCH models markets are incomplete so there is more than one price kernel for valuing contingent claims. This motivates the quest for selecting an appropriate price kernel. Different methods have been proposed for the choice of a price kernel. Some of them can be justified by economic equilibrium arguments. This paper studies risk-neutral dynamics of various classes of Generalized Hyperbolic GARCH models arising from different price kernels. We discuss the properties of these dynamics and show that for some special cases, some pricing kernels considered here lead to similar risk neutral GARCH dynamics. Real data examples for pricing European options on the S&P 500 index emphasize the importance of the choice of a price kernel.
The optimal reinsurance arrangement is identified whenever the reinsurer counterparty default risk is incorporated in a one-period model. Our default risk model allows the possibility for the reinsurer to fail paying in full the promised indemnity, whenever it exceeds the level of regulatory capital. We also investigate the change in the optimal solution if the reinsurance premium recognises or not the default in payment. Closed form solutions are elaborated when the insurer's objective function is set via some well-known risk measures. It is also discussed the effect of reinsurance over the policyholder welfare. If the insurer is Value-at-Risk regulated, then the reinsurance does not increase the policyholder's exposure for any possible reinsurance transfer, even if the reinsurer may default in paying the promised indemnity. Numerical examples are also provided in order to illustrate and conclude our findings. It is found that the optimal reinsurance contract does not usually change if the counterparty default risk is taken into account, but one should consider this effect in order to properly measure the policyholders's exposure. In addition, the counterparty default risk may change the insurer's ideal arrangement if the buyer and seller have very different views on the reinsurer's recovery rate.
This is the accepted version of the paper.This version of the publication may differ from the final published version. Abstract.
Permanent repository linkOptimal risk transfers are derived within an insurance group consisting of two separate legal entities, operating under potentially different regulatory capital requirements and capital costs. Consistent with regulatory practice, capital requirements for each entity are computed by either a Value-at-Risk or an Expected Shortfall risk measure. The optimality criterion consists of minimising the risk-adjusted value of the total group liabilities, with valuation carried out using a cost-of-capital approach. The optimisation problems are analytically solved and it is seen that optimal risk transfers often involve the transfer of tail risk (unlimited reinsurance layers) to the more weakly regulated entity. We show that, in the absence of a capital requirement for the credit risk that specifically arises from the risk transfer, optimal risk transfers achieve capital efficiency at the cost of increasing policyholder deficit. However, when credit risk is properly reflected in the capital requirement, incentives for tail-risk transfers vanish and policyholder welfare is restored.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.